v3.25.2
Revenue Disaggregation
12 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

NOTE 16 – Revenue Disaggregation

 

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The following table presents the Company’s disaggregated revenues by source:

        
   Year Ended March 31, 
   2025   2024 
Product:        
Human Care  $12,079,000   $10,110,000 
Animal Care   1,653,000    2,203,000 
Total Product Revenue   13,732,000    12,313,000 
Service/Royalty   556,000    422,000 
Total  $14,288,000   $12,735,000 

 

The following table shows the Company’s revenues by geographic region:

        
   Year Ended March 31, 
   2025   2024 
United States  $2,611,000   $3,058,000 
Europe   5,523,000    4,781,000 
Asia   2,317,000    2,298,000 
Latin America   2,962,000    1,726,000 
Rest of the World   875,000    872,000 
Total  $14,288,000   $12,735,000